465 related articles for article (PubMed ID: 27318945)
1. Emerging targets for radioprotection and radiosensitization in radiotherapy.
Kumar S; Singh RK; Meena R
Tumour Biol; 2016 Sep; 37(9):11589-11609. PubMed ID: 27318945
[TBL] [Abstract][Full Text] [Related]
2. Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization.
Maier P; Hartmann L; Wenz F; Herskind C
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26784176
[TBL] [Abstract][Full Text] [Related]
3. Chemical radiosensitizers for use in radiotherapy.
Wardman P
Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):397-417. PubMed ID: 17478086
[TBL] [Abstract][Full Text] [Related]
4. Role of metabolism in cancer cell radioresistance and radiosensitization methods.
Tang L; Wei F; Wu Y; He Y; Shi L; Xiong F; Gong Z; Guo C; Li X; Deng H; Cao K; Zhou M; Xiang B; Li X; Li Y; Li G; Xiong W; Zeng Z
J Exp Clin Cancer Res; 2018 Apr; 37(1):87. PubMed ID: 29688867
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in radiosensitization.
Linam J; Yang LX
Anticancer Res; 2015 May; 35(5):2479-85. PubMed ID: 25964520
[TBL] [Abstract][Full Text] [Related]
6. Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization.
Farhood B; Goradel NH; Mortezaee K; Khanlarkhani N; Salehi E; Nashtaei MS; Mirtavoos-Mahyari H; Motevaseli E; Shabeeb D; Musa AE; Najafi M
Clin Transl Oncol; 2019 Mar; 21(3):268-279. PubMed ID: 30136132
[TBL] [Abstract][Full Text] [Related]
7. Polyoxometalate-Based Radiosensitization Platform for Treating Hypoxic Tumors by Attenuating Radioresistance and Enhancing Radiation Response.
Yong Y; Zhang C; Gu Z; Du J; Guo Z; Dong X; Xie J; Zhang G; Liu X; Zhao Y
ACS Nano; 2017 Jul; 11(7):7164-7176. PubMed ID: 28640996
[TBL] [Abstract][Full Text] [Related]
8. Molecular targets that sensitize cancer to radiation killing: From the bench to the bedside.
Sriramulu S; Thoidingjam S; Brown SL; Siddiqui F; Movsas B; Nyati S
Biomed Pharmacother; 2023 Feb; 158():114126. PubMed ID: 36521246
[TBL] [Abstract][Full Text] [Related]
9. Emodin attenuates radioresistance induced by hypoxia in HepG2 cells via the enhancement of PARP1 cleavage and inhibition of JMJD2B.
Hwang SY; Heo K; Kim JS; Im JW; Lee SM; Cho M; Kang DH; Heo J; Lee JW; Choi CW; Yang K
Oncol Rep; 2015 Apr; 33(4):1691-8. PubMed ID: 25607726
[TBL] [Abstract][Full Text] [Related]
10. Exploitation of hypoxia for radiation therapy: a lesson from phenothiazines.
Kale RK
Med Hypotheses; 1996 Aug; 47(2):107-10. PubMed ID: 8869925
[TBL] [Abstract][Full Text] [Related]
11. Inhibitor of Apoptosis (IAP) proteins as therapeutic targets for radiosensitization of human cancers.
Fulda S
Cancer Treat Rev; 2012 Oct; 38(6):760-6. PubMed ID: 22342104
[TBL] [Abstract][Full Text] [Related]
12. Cooperative effect of BI-69A11 and celecoxib enhances radiosensitization by modulating DNA damage repair in colon carcinoma.
Pal I; Dey KK; Chaurasia M; Parida S; Das S; Rajesh Y; Sharma K; Chowdhury T; Mandal M
Tumour Biol; 2016 May; 37(5):6389-402. PubMed ID: 26631035
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of radiotherapy with DNA topoisomerase I-targeted drugs.
Chen AY; Chou R; Shih SJ; Lau D; Gandara D
Crit Rev Oncol Hematol; 2004 May; 50(2):111-9. PubMed ID: 15157660
[TBL] [Abstract][Full Text] [Related]
14. Emerging Strategies of Nanomaterial-Mediated Tumor Radiosensitization.
Xie J; Gong L; Zhu S; Yong Y; Gu Z; Zhao Y
Adv Mater; 2019 Jan; 31(3):e1802244. PubMed ID: 30156333
[TBL] [Abstract][Full Text] [Related]
15. DNA topoisomerase I-targeting drugs as radiation sensitizers.
Chen AY; Choy H; Rothenberg ML
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):39-46. PubMed ID: 10550825
[TBL] [Abstract][Full Text] [Related]
16. Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.
Lee TK; Stupans I
J Pharm Pharmacol; 2002 Nov; 54(11):1435-45. PubMed ID: 12495545
[TBL] [Abstract][Full Text] [Related]
17. A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3.
Huang CY; Tai WT; Hsieh CY; Hsu WM; Lai YJ; Chen LJ; Shiau CW; Chen KF
Cancer Lett; 2014 Jul; 349(2):136-43. PubMed ID: 24735751
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
[TBL] [Abstract][Full Text] [Related]
19. Radiation-induced signaling pathways that promote cancer cell survival (review).
Hein AL; Ouellette MM; Yan Y
Int J Oncol; 2014 Nov; 45(5):1813-9. PubMed ID: 25174607
[TBL] [Abstract][Full Text] [Related]
20. Cancer Radiosensitizers.
Wang H; Mu X; He H; Zhang XD
Trends Pharmacol Sci; 2018 Jan; 39(1):24-48. PubMed ID: 29224916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
